Syncona Limited (SYNC) Ordinary NPV
0.50p
(0.50%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.50p
(0.50%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.50p
(0.50%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
99.70p
100.20p
131.60p
178.95
99.70p
99.20p
99.20p
-44.29%
0.20p (0.20%) Previous:
0.20p
552,324
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
| 1 week 1W | 7.12% | 1 year 1Y | 16.36% |
|---|---|---|---|
| 1 month 1M | 9.82% | 2 years 2Y | 48.71% |
| 3 months 3M | 17.06% | 3 years 3Y | 54.18% |
| 6 months 6M | 11.59% | 5 years 5Y | 55.01% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
| Benchmark: | FTSE 250 TR GBP |
|---|---|
| Annual management charge: | n/a |
| Performance fee: | No |
| Ongoing charge: | 1.74% |
| Dividend yield: | n/a |
| Dividend frequency: | Annually |
| Total assets: | £1,131m |
| Gross gearing: | 0% |
| Market capitalisation:Market cap.: | £630m |
| Shares in issue: | 631.82 million |
| Legal structure | Closed Ended Investment Company |
| Domicile: | Guernsey |
| ISIN | GG00B8P59C08 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
| Estimated NAV: | 178.95p |
|---|---|
| Latest actual NAV: | 178.95p |
| Latest actual NAV date: | 30 September 2024 |
| Premium/Discount: | -44.29% |
| 12m average Premium/Discount: | -35.99% |
| NAV frequency: | Quarterly |
| Security | Weight |
|---|---|
| Capital Pool | 30.81% |
| Spur Therapeutics | 13.76% |
| Beacon Therapeutics | 9.87% |
| Autolus Therapeutics PLC ADR | 7.29% |
| Quell Therapeutics | 6.99% |
| Resolution Therapeutics | 5.56% |
| Purespring Therapeutics | 4.47% |
| Omass Therapeutics | 4.34% |
| Anaveon | 3.14% |
| Crt Pioneer Fund | 2.89% |
Top 10 sectors currently unavailable.
| Country | Weight |
|---|---|
| United Kingdom | 8.03% |
| United States | 0.13% |
Key Dates
| Launch date: | 26 October 2012 |
|---|---|
| Financial year end: | March |
| Next AGM: | August 2025 |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.